Andrew L. Pecora, MD
Advertisement
Articles by Andrew L. Pecora, MD
Advertisement
Latest Updated Articles
Dr. Pecora on Key Efficacy Findings from the DREAMSEQ Trial in BRAF-Mutated MelanomaPublished: November 3rd 2022 | Updated:
Dr. Pecora on Oncology Care Model InnovationsPublished: August 19th 2016 | Updated:
Dr. Pecora on Patient Management Payments Under the OCMPublished: August 12th 2016 | Updated:
Dr. Pecora on How the OCM Will Transform Operations For His Physician GroupPublished: August 12th 2016 | Updated:
Dr. Pecora on How MACRA Needs Fine TuningPublished: August 12th 2016 | Updated:
Dr. Pecora on the Medicare Part B Drug Payment ModelPublished: August 12th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5